SPX 0.02% VIX 2.34%
DOW, NASDAQ POST RECORD CLOSE AS STOCKS EDGE HIGHER 
STOCKS UNDER INCREASING PRESSURE MONDAY AS SECOND-QUARTER EARNINGS SEASON OPENS 
SYMANTEC SHARES PLUNGE ON REPORTED HALT IN BROADCOM DEAL TALKS 
NEW YORK FED'S MANUFACTURING GAUGE SHOWS JULY REBOUND 
NEED TO KNOW: HOW STOCK-MARKET INVESTMENTS ARE LIKE FYRE FESTIVAL TICKETS 
CITI SHARES UP IN PREMARKET AFTER SALES AND PROFIT RISE 
CALLON PETROLEUM SAYS IT WILL BUY CARRIZO OIL & GAS FOR $3.2 BILLION 
U.S. STOCKS END AT RECORD HIGHS, FUELED BY OPTIMISM OVER FED INTEREST-RATE CUTS 
FACEBOOK STOCK MOVES HIGHER AFTER REPORT OF $5 BILLION FTC SETTLEMENT 
THERE ARE 5 THINGS ATOP INVESTORS' MINDS AS EARNINGS SEASON IS ABOUT TO BEGIN 
Mon, Jul 15 6:47pm

Compare CNCE



Concert Pharmaceuticals Inc [CNCE]
$11.45 0.03 (0.27%)

CNCE Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 270 Million
CNCE Description

Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the current approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.


Visit Website

CNCE Earnings

EPS -0.93 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Thu, May 2, 2019 (74 days ago) +12.37%

CNCE Dividend

Yield --
Ex-Date --
Pay Date --
History --

CNCE Charts

$9.30
52 Week Range
$17.83
Apr 18, 2019
Mar 21, 2019



Symbol Price Day % YTD %
CNCE $11.45 0.27% -15.62%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy